Scotiabank Forecasts Albemarle’s Q1 Earnings (NYSE:ALB)

Albemarle Co. (NYSE:ALB) – Equities researchers at Scotiabank issued their Q1 2025 earnings per share (EPS) estimates for Albemarle in a note issued to investors on Tuesday, February 18th. Scotiabank analyst B. Isaacson forecasts that the specialty chemicals company will post earnings of ($0.14) per share for the quarter. Scotiabank has a “Sector Perform” rating and a $75.00 price target on the stock. The consensus estimate for Albemarle’s current full-year earnings is $0.74 per share. Scotiabank also issued estimates for Albemarle’s FY2026 earnings at $2.51 EPS.

Albemarle (NYSE:ALB) last posted its quarterly earnings results on Wednesday, February 12th. The specialty chemicals company reported ($1.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.49). Albemarle had a negative net margin of 21.93% and a negative return on equity of 1.72%.

Several other brokerages have also recently issued reports on ALB. Citigroup reduced their target price on Albemarle from $115.00 to $85.00 and set a “neutral” rating on the stock in a report on Wednesday, February 12th. KeyCorp dropped their price target on Albemarle from $127.00 to $122.00 and set an “overweight” rating for the company in a research report on Friday, February 14th. Deutsche Bank Aktiengesellschaft dropped their price target on Albemarle from $109.00 to $105.00 in a research report on Wednesday, February 12th. Piper Sandler dropped their price target on Albemarle from $90.00 to $85.00 and set an “underweight” rating for the company in a research report on Thursday. Finally, Oppenheimer dropped their price target on Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Two investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $109.68.

Albemarle Trading Down 1.4 %

Shares of ALB stock opened at $82.51 on Thursday. Albemarle has a 12-month low of $71.97 and a 12-month high of $143.19. The company has a current ratio of 1.95, a quick ratio of 1.19 and a debt-to-equity ratio of 0.39. The stock’s 50-day moving average price is $87.29 and its 200-day moving average price is $92.07. The stock has a market capitalization of $9.70 billion, a price-to-earnings ratio of -7.37, a price-to-earnings-growth ratio of 7.04 and a beta of 1.59.

Institutional Investors Weigh In On Albemarle

Several hedge funds have recently added to or reduced their stakes in ALB. Quarry LP boosted its holdings in Albemarle by 1,400.0% in the third quarter. Quarry LP now owns 270 shares of the specialty chemicals company’s stock valued at $26,000 after purchasing an additional 252 shares during the last quarter. Assetmark Inc. boosted its holdings in Albemarle by 340.6% in the fourth quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company’s stock valued at $26,000 after purchasing an additional 235 shares during the last quarter. Trust Co. of Vermont boosted its holdings in Albemarle by 606.5% in the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company’s stock valued at $28,000 after purchasing an additional 279 shares during the last quarter. Eastern Bank purchased a new stake in Albemarle in the third quarter valued at $31,000. Finally, First Community Trust NA boosted its holdings in Albemarle by 55.0% in the fourth quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company’s stock valued at $34,000 after purchasing an additional 142 shares during the last quarter. 92.87% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Albemarle

In related news, CEO J Kent Masters sold 2,525 shares of the company’s stock in a transaction on Thursday, December 5th. The stock was sold at an average price of $101.12, for a total value of $255,328.00. Following the transaction, the chief executive officer now directly owns 73,747 shares of the company’s stock, valued at $7,457,296.64. This represents a 3.31 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.38% of the company’s stock.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.